Jump to:
loading...| Preferred Name |
dapagliflozin |
|
| Synonyms |
DAPA (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol |
|
| Definitions |
This is any condition in which the main influencing factor is dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor used for managing diabetes mellitus type 2. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001302 |
|
| created_by |
slaulederkind |
|
| creation_date |
2024-03-01T10:57:39Z |
|
| database_cross_reference |
CHEBI:85078 PMID:37383701 MESH:C529054 |
|
| definition |
This is any condition in which the main influencing factor is dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor used for managing diabetes mellitus type 2. |
|
| has_exact_synonym |
DAPA (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0001302 |
|
| label |
dapagliflozin |
|
| notation |
XCO:0001302 |
|
| prefLabel |
dapagliflozin |
|
| treeView | ||
| subClassOf |
Create mapping